Anthera Pharmaceuticals to host Lupus symposium in San Francisco

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today announced that it is inviting its shareholders and investors to a symposium on Systemic Lupus Erythematosus (SLE) at 3:30 PM on Wednesday, January 14th at the Mystic Hotel in San Francisco, CA.

"Right Patient, Right Therapy"
A Symposium on Systemic Lupus Erythematosus
Wednesday, January 14th, 3:30 – 5:00 PM
Mystic Hotel, 417 Stockton Street, San Francisco, CA

"Right Patient, Right Therapy" will bring together several immunology experts, including Dr. David Wofsy, Dr. Joan Merrill, and Dr. Vibeke Strand, to provide their perspectives on recent developments in the treatment of SLE and BAFF inhibition.

"The wealth of new information released over the past year regarding the treatment of SLE and BAFF inhibition provides an excellent opportunity to re-evaluate how we think about SLE, from optimal trial design to improving patient selection," said Dr. Colin Hislop, Anthera's Chief Medical Officer. "We look forward to having top experts in the field give us their views on what recent developments mean for patients with lupus."


Anthera Pharmaceuticals, Inc.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Drug combinations may help to slow the progression of diabetic kidney disease